Monoclonal antibody treatment for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. Monoclonal antibodies may also neutralize a virus. Eligible to high-risk individuals who have tested positive for COVID within the last 10 days.
Patients who are defined under high-risk criteria should consider Monoclonal Antibody Treatment since it is an extra layer of protection to keep you from getting especially sick from the virus. These high-risk categories include:
Does not require fasting.
*Must have insurance